Rare Cardiology Virtual Interactive Poster/Presentation Sessions

Welcome to Pfizer’s Medical Affairs-Rare Cardiology Virtual Poster/Presentation Sessions!

We are delighted you could join us! We will be showcasing our European Society of Cardiology-Heart Failure 2026 posters and presentations in an interactive online gallery style forum.  This event is designed to provide you with an engaging and informative experience, allowing you to explore and discuss our research findings with the presenters. This event is designed for U.S healthcare providers: 

1. Long-Term Treatment with Tafamidis in ATTR-CM: 7.5-year Outcomes From the Phase 3 Open-Label Long-term Extension Study. Damy et al.

2. Improvements in Cardiac Functional Status and Health-Related Quality of Life in Patients Receiving Early Access Tafamidis. Crespo-Leiro et al.

3. Outcomes With Early Access Tafamidis in Patients With Variant Transthyretin Amyloid Cardiomyopathy. Witteles et al.

If you have yet to register, please click the registration tab to select a session date you'd like to join.

We look forward to an engaging discussion!